v3.26.1
Composition of Certain Consolidated Financial Statement Line Items (Tables)
6 Months Ended
Jun. 30, 2026
Composition of Certain Consolidated Financial Statement Line Items  
Schedule of accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

JUNE 30, 

​

DECEMBER 31, 

​

​

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

Accrued compensation

​

$

8,013

​

$

12,434

​

Accrued research and development expenses

​

 

17,348

​

 

12,404

​

Accrued clinical expenses

​

​

22,015

​

​

15,791

​

Accrued professional services

​

​

3,138

​

​

4,470

​

Accrued other liabilities

​

 

1,873

​

 

1,444

​

Total accrued expenses and other current liabilities

​

$

52,387

​

$

46,543

​

​

​

​

​

​

​

​

​

​